Ningbo INNO PHARMCHEM CO.,LTD. highlights the critical role of Sodium Butazolidine (CAS 129-18-0) in the pharmaceutical sector. As a potent anti-inflammatory agent, it is a key ingredient in medications designed to treat debilitating conditions such as arthritis and gout. This article focuses on its pharmaceutical significance and the considerations for procurement.

Sodium Butazolidine is recognized for its effectiveness as an anti-inflammatory drug. Its standard specification includes a white crystalline powder appearance and a minimum purity of 99%. The compound's molecular formula is C19H19N2NaO2, with a molecular weight of 330.36. These details are essential for manufacturers to verify the quality and suitability of the material for their specific applications. The consistent quality available from Sodium Butazolidine CAS 129-18-0 suppliers is a major factor in its widespread use.

The primary therapeutic uses of Sodium Butazolidine include providing relief from inflammation and pain associated with various musculoskeletal disorders. It is particularly noted for its efficacy in Sodium Butazolidine for arthritis treatment and its contribution to managing gout symptoms. For pharmaceutical companies, understanding the benefits and applications of this compound is crucial for product development and market positioning.

When considering the procurement of this chemical, prospective buyers often evaluate the Sodium Butazolidine price from different international markets. China has emerged as a significant source for high-quality pharmaceutical raw materials, offering competitive Sodium Butazolidine buy opportunities. It is imperative for purchasers to work with reputable Sodium Butazolidine pharmaceutical grade providers who can guarantee product integrity and compliance with regulatory standards.

In conclusion, Sodium Butazolidine (CAS 129-18-0) stands out as a valuable pharmaceutical raw material due to its anti-inflammatory properties. By focusing on sourcing from reliable suppliers and ensuring high purity, the pharmaceutical industry can continue to benefit from its therapeutic applications in treating inflammatory diseases.